QuantHealth, an Israeli clinical trial simulation software provider, raised $45 million in Series B funding, CEO Orr Inbar tells Axios Pro exclusively.
Why it matters: Demand for modeling and simulation software is surging as AI promises to cut drug development costs and timelines.
